When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Rift Valley fever

Last reviewed: 26 Nov 2024
Last updated: 22 Aug 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fever ≥37.5°C
Full details

Other diagnostic factors

  • headache
  • myalgia
  • arthralgia
  • weakness
  • backache
  • neck stiffness
  • dizziness
  • chills
  • loss of appetite
  • vomiting
  • photophobia
  • pain behind the eyes
  • vision impairment
  • retinitis
  • meningoencephalitis
  • hepatitis
  • acute kidney injury
  • haemorrhagic fever
Full details

Risk factors

  • livestock handling through occupational exposure or homestead exposure
  • consuming raw animal fluids or tissue
  • genetic polymorphism
  • advanced age
  • mosquito exposure
  • sex
Full details

Diagnostic investigations

1st investigations to order

  • reverse transcriptase-polymerase chain reaction (RT-PCR)
  • serum IgM or IgG detection with ELISA
  • FBC
  • serum electrolytes
  • LFTs
Full details

Investigations to consider

  • coagulation studies
  • serum creatinine and urea
  • creatine phosphokinase (CPK)
Full details

Treatment algorithm

ACUTE

all patients

Contributors

Authors

A. Desiree LaBeaud, MD, MS

Associate Professor

Pediatric Infectious Diseases

Stanford University

Bechtel Faculty Scholar

Stanford Child Health Research Institute

Stanford

CA

Disclosures

ADL has a grant from the USDA working on Rift Valley fever in milk research. ADL is the author of several references cited in this topic.

Keli Gerken, DVM

Postdoctoral scholar

Infectious diseases

Stanford University

Stanford

CA

Disclosures

KG has received a funded fellowship through the University of Liverpool to study endemic Rift Valley fever patterns in Kenya. She is also the author of references cited in this topic.

Peer reviewers

Anita K. McElroy, MD, PhD

Assistant Professor

Emory University

Atlanta

GA

Disclosures

AKM receives funding for RVFV-related research from Burroughs Wellcome, NIH, and Children’s Healthcare of Atlanta. AKM consults for Regeneron.

Tariq Ahmed Madani, MD, FRCPC

Chairman

Section of Infectious Diseases and Infection Control & Environmental Health unit

Viral Hemorrhagic Fever Scientific Chair

Faculty of Medicine

King Abdulaziz University

Jeddah

Saudi Arabia

Disclosures

TAM is the author of a reference cited in this topic.

  • Differentials

    • Malaria infection
    • West Nile virus
    • Crimean-Congo haemorrhagic fever
    More Differentials
  • Guidelines

    • CDC Yellow Book: health information for international travel - viral hemorrhagic fevers
    • Viral haemorrhagic fever: sample testing advice
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer